Rite-Aid (RAD) Price Target Lifted to $9.50 at Evercore ISI on EnvisionRx Deal
Tweet Send to a Friend
Evercore ISI analyst Ross Muken reiterated a Buy rating and boosted his price target on Rite-Aid (NYSE: RAD) to $9.50 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
